USPTO serial 88524189
MILESTONE PHARMACEUTICALS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 2, 2023
- Examiner
- BECHHOFER, YOCHEVED D
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with MILESTONE PHARMACEUTICALS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Milestone Pharmaceuticals USA, Inc.
Charlotte, NC
Other trademarks owned by Milestone Pharmaceuticals USA, Inc.
Milestone Pharmaceuticals USA, Inc.
Charlotte, NC
Other trademarks owned by Milestone Pharmaceuticals USA, Inc.
Milestone Pharmaceuticals USA, Inc.
Charlotte, NC
Other trademarks owned by Milestone Pharmaceuticals USA, Inc.
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Promoting collaboration within the scientific, research and medical communities to achieve advances in the field of cardiovascular disorders; Promoting the exchange of information and resources within the scientific research and medical communities to achieve advances in the field of cardiovascular disorders | ACTIVE | — |
| 042 | Providing medical and scientific research information in the field of heart disease and clinical trials; providing medical and scientific research information in the field of cardiovascular disorders and clinical trials; pharmaceutical research services in the field of heart disease and cardiovascular system; pharmaceutical drug development services in the field of heart disease and cardiovascular system; pharmaceutical research and development in the field of heart disease and cardiovascular system; medical and scientific research, namely, conducting clinical trials for others in the field of heart disease and cardiovascular system; providing medical and scientific research information in the field of pharmaceuticals and clinical trials | ACTIVE | — |
| 044 | Providing a resource website featuring information in the field of the treatment of episodic cardiovascular conditions; providing a resource website featuring information for people living with atrial fibrillation/atrial flutter; providing a resource website featuring information for people living with myocardial ischemia including angina; providing a resource website featuring information for people living with supraventricular tachycardias including paroxysmal | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Milestone Pharmaceuticals USA, Inc.
- Other trademarks owned by Milestone Pharmaceuticals USA, Inc.
- Other trademarks owned by Milestone Pharmaceuticals USA, Inc.
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named MILESTONE PHARMACEUTICALS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 12, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 12, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jul 12, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| May 2, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| May 2, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 14, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 14, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 25, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 12, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 31, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 31, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 31, 2022 | ALIE | ASSIGNED TO LIE | — |
| Nov 4, 2022 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| May 8, 2022 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| May 8, 2022 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 8, 2022 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 1, 2021 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Apr 1, 2021 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Oct 1, 2020 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Apr 1, 2020 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Apr 1, 2020 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Apr 1, 2020 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Mar 25, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 24, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 24, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 24, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 24, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 24, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 22, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 29, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 23, 2019 | NWAP | NEW APPLICATION ENTERED | — |